Trial Profile
Eculizumab in HELLP Syndrome
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2023
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Pregnancy complications
- Focus Pharmacodynamics
- 13 Nov 2023 Status changed from suspended to completed.
- 22 Jun 2023 Planned End Date changed from 4 Jun 2023 to 4 Sep 2023.
- 22 Jun 2023 Planned primary completion date changed from 31 May 2023 to 31 Aug 2023.